Kingstone Capital Partners Texas LLC Invests $7.80 Million in GE HealthCare Technologies Inc. $GEHC

Key Points

• Kingstone Capital Partners Texas LLC has acquired a new stake in GE HealthCare Technologies, purchasing 98,805 shares valued at approximately $7.8 million.
• GE HealthCare Technologies reported $1.06 EPS for the latest quarter, surpassing expectations and reflecting a 3.5% increase in revenue year-over-year.
• The company declared a quarterly dividend of $0.035 per share, translating to an annualized dividend yield of 0.2%.

Kingstone Capital Partners Texas LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 98,805 shares of the company's stock, valued at approximately $7,804,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC grew its holdings in GE HealthCare Technologies by 3.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company's stock valued at $464,226,000 after purchasing an additional 176,572 shares during the period. JPMorgan Chase & Co. grew its stake in shares of GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company's stock valued at $414,894,000 after acquiring an additional 1,711,963 shares during the period. Dimensional Fund Advisors LP raised its stake in GE HealthCare Technologies by 3.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company's stock worth $398,975,000 after acquiring an additional 157,839 shares during the period. Canada Pension Plan Investment Board lifted its holdings in GE HealthCare Technologies by 15.2% during the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company's stock valued at $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of GE HealthCare Technologies by 3.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company's stock worth $247,708,000 after purchasing an additional 109,858 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.2%

GEHC stock traded down $0.14 during midday trading on Monday, reaching $74.77. 3,093,114 shares of the company traded hands, compared to its average volume of 3,961,734. The firm has a market capitalization of $34.14 billion, a price-to-earnings ratio of 15.32, a P/E/G ratio of 2.86 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The business has a 50 day moving average of $74.53 and a 200-day moving average of $73.10. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the previous year, the firm earned $1.00 earnings per share. GE HealthCare Technologies's quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is 2.87%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on GEHC. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday. BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Wall Street Zen lowered shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a report on Saturday. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Finally, Citigroup boosted their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $88.40.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.